Press Releases

Acroscell Develops Drugs Based on Neuropharmacology in Order to Treat Many Different Neurological Diseases

The Launch of U-Load Dextramer® with Peptide Receptive MHC I and MHC II Monomers Greatly Expands Flexibility while Ensuring Reliable Sensitivity in Exploring Diversity of Cellular Immune Responses

Dear Nicole, Immudex ApS, a pioneering life science company spearheading the global adoption of precision immune monitoring, has announced the launch of the new U-Load Dextramer® product line.

MicrobioSeq Introduces Skin Microbiome Solutions to Accelerate Research and Practice

VERICHEM LABORATORIES OFFERS EXTENSIVE LINE OF BIO-SYNTHETIC CLINICAL REFERENCE MATERIALS FOR URINE CHEMISTRIES

VERICHEM now offers clinical laboratorians an extensive line of liquid stable and ready-to-use biosynthetic clinical reference materials for urine chemistry assays.

Creative Biogene Provides Oligonucleotide Synthesis Services to Promote Research in Genomics and Molecular Biology

Takara Bio enters into a license and supply agreement of RetroNectin® with BioNTech Cell & Gene Therapies GmbH

Takara Bio Inc. has announced that it has entered into a License and Supply Agreement with BioNTech Cell & Gene Therapies GmbH ("BioNTech").

IntegrateRNA Develops Customized CircRNA Pull-down Detection Service to Identify The Interaction Between miRNA/RBP and circRNA

Irish pharmaceutical R&D company, APC, unveils world’s first ‘Medicine Accelerator’ with the help of Enterprise Ireland

APC Ltd, the award-winning Irish pharmaceutical research and development company, is investing €25M and creating 120 jobs through the formation of a ‘Global Centre of Excellence for Vaccine and Advanced Therapeutic Research and Manufacturing’.

Microbiosci Releases Optimized Real-time PCR Kits for RNA detection and Gene Sequencing

BOC Sciences Provides High-quality Raw Materials to Accelerate mRNA Vaccine Supply

Shimmer Adopts the V3 Framework to Validate its Verisense® Wearable Sensing Platform for Clinical Trials

The Verisense IMU (inertial measurement unit) was the first Shimmer sensor validated following the V3 framework championed by the Digital Medicine Society (DiMe).

Optima Laboratory Resource Management System V2021.1 Software Release Announcement

Optima, a software company aiming to provide solutions to address laboratory resource management challenges, has announced the new Optima Laboratory Resource Management System — LRMS version 2021.1.

PolyNovo’s NovoSorb® BTM technology featured in a new digital film series presented by the ICBA and produced by BBC StoryWorks Commercial Productions

PolyNovo, developers of innovative medical devices, has announced that its NovoSorb® BTM technology has been featured in a new digital film series presented by the ICBA and produced by BBC StoryWorks Commercial Productions.

Bio-Gate and Avicanna complete first phase of development on CBD and Micro Silver BG™ based skin care products for global commercialization

About Bio-Gate: Bio-Gate AG is one of the world’s leading providers of innovative technologies and customised solutions for health and hygiene. Our aim is to make living together safer and healthier and to improve the well-being of all individuals. Bio-Gate enhances materials and products with its technologies and antimicrobial and antiviral strategies, and, thereby improves the quality of life of people and animals alike. The company specializes in equipping materials and surfaces with antiviral and antimicrobial properties. Bio-Gate AG enhances materials and products, particularly in the field of medical technology, such as the coating of implants or wound dressings. In addition, Bio-Gate technologies are used to provide consumer, industrial and hygiene products, such as paints, coatings, plastics or protective film sprays with antiviral and antimicrobial properties, thus enhancing them in a unique way. Bio-Gate also uses its unique and multi-functional additive MicroSilver BG in dermatology and cosmetics as well as wound care to provide these kind of products with long-lasting antimicrobial, anti-inflammatory and Microbiome friendly properties.

Stability Screening Meets Tetravalent Bispecifics In Next Generation Collaboration

Protein Stable, a joint venture between Applied Photophysics and Fluorescence Innovations, has announced a collaboration with F-star Therapeutics, a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm shift in cancer therapy

Nottingham University Hospitals NHS Trust selects Indica Labs to deliver their Digital Pathology Solution with HALO AP®

Nottingham University Hospitals (NUH) NHS Trust, has announced the selection of Indica Labs, the world’s leading provider of computational pathology software and services, to aid in full digitisation of the pathology workflow.

The clinical results of SCO-267 was presented at the Virtual 81st Scientific Sessions - American Diabetes Association: First report on the clinical data of a GPR40 full agonist in the phase 1 trial

SCOHIA PHARMA, a drug discovery bioventure focusing on the field of lifestyle-related diseases such as cardiovascular, metabolic, and renal diseases has announced the results of a phase 1 clinical trial for SCO-267, an orally bioavailable GPR40 full agonist, at the Virtual 81st Scientific Sessions - American Diabetes Association, June 25-29, 2021.

Creative Biostructure Enables Exosome Isolation and Purification for Various Samples

Profacgen Provides an Ultimate Solution of Animal-free Protein Production Services for Research Needs

BioIVT Acquires Serum, Plasma and Reagent Producer and IVD Manufacturer Valley Biomedical Products & Services

This transaction will expand BioIVT’s in vitro diagnostic, cell and gene therapy support capabilities.